Benserazide HCl contains not less than 98.5% and not more than 101.0% of C10H16ClN3O5, calculated with reference to the anhydrous substance.

共有 1 個藥物證書使用此成份

申請商
新雙隆生技股份有限公司 
適應症
帕金森氏症。
含量
發證日期
2011-12-22